Search
for
Sort by
Research 691–720 of 1000+
- Androgen excess is the key element in polycystic ovary syndrome
- Prolactin and the Skin: A Dermatological Perspective on an Ancient Pleiotropic Peptide Hormone
- Polycystic Ovarian Syndrome
- Alopecia Areata Update
- Prevalence of polycystic ovaries in women with androgenic alopecia
- Lichen Planopilaris and Frontal Fibrosing Alopecia as Model Epithelial Stem Cell Diseases
- Insulin sensitiser agents alone and in co-treatment with r-FSH for ovulation induction in PCOS women
- Comparison of finasteride versus flutamide in the treatment of hirsutism
- Advanced nanocarrier- and microneedle-based transdermal drug delivery strategies for skin diseases treatment
- Telogen effluvium
- Androgen receptors and their biology
- Polycystic ovary syndrome and the risk of obstructive sleep apnea: a meta-analysis and review of the literature
- Treatment of MSCs with Wnt1a-conditioned medium activates DP cells and promotes hair follicle regrowth
- Sex Steroid Hormone Receptors in Human Skin Appendage and its Neoplasms
- Sex Hormone-Binding Globulin (SHBG) as an Early Biomarker and Therapeutic Target in Polycystic Ovary Syndrome
- Metabolic syndrome and the skin: a more than superficial association. Reviewing the association between skin diseases and metabolic syndrome and a clinical decision algorithm for high risk patients
- Diagnosis and Management of Alopecia in Children
- Influence of spironolactone treatment on endothelial function in non-obese women with polycystic ovary syndrome
- Nutrition Strategy and Life Style in Polycystic Ovary Syndrome—Narrative Review
- Hidradenitis suppurativa: an-androgen-dependent disorder
- Role of Zinc in Mucosal Health and Disease: A Review of Physiological, Biochemical, and Molecular Processes
- Alternative treatment of polycystic ovary syndrome: pre-clinical and clinical basis for using plant-based drugs
- Cutaneous Side Effects of Oral Contraceptives
- Prevalence of CYP21 mutations and IRS1 variant among women with polycystic ovary syndrome and adrenal androgen excess
- 5-Alpha reductase deficiency
- Natural Molecules in the Management of Polycystic Ovary Syndrome (PCOS): An Analytical Review
- Pregnancy and the Skin
- FOXN1 Deficiency: from the Discovery to Novel Therapeutic Approaches
- Use of Insulin-Sensitizing Agents in Patients With Polycystic Ovary Syndrome
- Female pattern hair loss, sebum excretion and the end-organ response to androgens